Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 11Unknown 5Terminated 2Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 18Breast 10Thoracic 4Sarcoma 3Genitourinary 3Gynecologic 2Dermatologic 2CNS 2Tumor-Agnostic 1Plasma cell 1Classical hematology 1

Conditions

Glioma 1Glioblastoma 1Central Nervous System Neoplasms 1Astrocytoma 1

Interventions

Temozolomide 80Radiotherapy 41Bevacizumab 35Radiosurgery 23Magnetic Resonance Spectroscopy 20Cyclophosphamide 17Radiation 14Irinotecan 13Carboplatin 12Topotecan 11Nivolumab 11Lomustine 11Filgrastim 10Everolimus 10Etoposide 10Erlotinib Hydrochloride 10pembrolizumab 9Radiotherapy, Intensity-Modulated 9Ipilimumab 9Granulocyte Colony-Stimulating Factor 8Carmustine 8antineoplaston AS 2-1 7antineoplaston A10 7Surgical Procedures, Operative 7Mental Status and Dementia Tests 7Isotretinoin 7Granulocyte-Macrophage Colony-Stimulating Factor 7sargramostim 6Vincristine 6TPI-287 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Neoadjuvant Therapy × CNS × Clear all
NCT04209790 2025-11-10

NeoGlio

Geisinger Clinic

Phase 2 Terminated
2 enrolled 7 charts
CNS

Glioblastoma, Glioma

NCT00045721 2009-10-16

Carmustine Implants and O(6)-Benzylguanine in Treating Children With Recurrent Malignant Glioma

Pediatric Brain Tumor Consortium

Phase 1 Terminated
3 enrolled
CNS

Astrocytoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡